Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

CR1 technology licensed to CytoTherapeutics

May 10, 1996

Gryphon, SKB to study mirror image proteins

May 10, 1996

Hyal to study agents for macular degeneration

May 10, 1996

RiboGene and Abbott collaborate on antifungal drugs

May 10, 1996

BioChem, Oncogene to investigate treatments for HCV, HIV

May 10, 1996

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Cadus/Solvay yeast-based drug discovery program receives boost from EC

May 3, 1996

Drug discovery agreement reached by CombiChem and Teijin

May 3, 1996

Anaderm Research formed to develop skin and hair therapeutics

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...